MAP2K1 and cancer: E6201 is a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-1 (MEK1) and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1 (MEKK1), as well as other kinases that have a role in cancer development.